5N5J
Human MMP12 in complex with 3-(5-(1,2-dithiolan-3-yl)pentanamido)propane-1-sulfonate
5N5J の概要
| エントリーDOI | 10.2210/pdb5n5j/pdb |
| 分子名称 | Macrophage metalloelastase, ZINC ION, CALCIUM ION, ... (6 entities in total) |
| 機能のキーワード | mmp12, lipoic acid, inhibitor, hydrolase |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Secreted, extracellular space, extracellular matrix : P39900 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 18138.08 |
| 構造登録者 | |
| 主引用文献 | Fragai, M.,Comito, G.,Di Cesare Mannelli, L.,Gualdani, R.,Calderone, V.,Louka, A.,Richichi, B.,Francesconi, O.,Angeli, A.,Nocentini, A.,Gratteri, P.,Chiarugi, P.,Ghelardini, C.,Tadini-Buoninsegni, F.,Supuran, C.T.,Nativi, C. Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX). J. Med. Chem., 60:9003-9011, 2017 Cited by PubMed Abstract: Oxaliplatin (OXA) is a valuable and largely used cancer drug which induces a serious and intractable neuropathy. The lipoyl-homotaurine derivative (ADM_12) reverts in vivo OXA-induced neuropathy, and it is an effective antagonist of the nociceptive sensor channel TRPA1. Unprecedentedly, this safe analgesic showed a synergy with OXA in vitro and proved to inhibit CA IX, a relevant therapeutic target, clearly interfering with pancreatic cancer cells' aggressiveness. PubMed: 29048889DOI: 10.1021/acs.jmedchem.7b01237 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.8 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






